MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) Return on equity 2019–2025
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. (MHUAF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
3.6%FY2025 · since FY2019: 25.9% → 3.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 3.6% | -3.2 pp |
| FY2024 | 6.8% | -1.1 pp |
| FY2023 | 7.9% | +3.4 pp |
| FY2022 | 4.5% | -14.9 pp |
| FY2021 | 19.4% | -3.0 pp |
| FY2020 | 22.5% | -3.4 pp |
| FY2019 | 25.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More MHUAF financial trends
MHUAF RevenueMHUAF Net incomeMHUAF Net marginMHUAF Gross profitMHUAF Gross marginMHUAF Operating incomeMHUAF Operating marginMHUAF Operating cash flowMHUAF Free cash flowMHUAF Capital expendituresMHUAF Stock buybacksMHUAF Dividends paidMHUAF Total assetsMHUAF Total liabilitiesMHUAF Shareholders’ equityMHUAF overview →